Bernard Poussot

Mr. Poussot has been an Advisor for AptamiR since 2012. He was formerly the Chairman, CEO, & President of Wyeth Pharmaceuticals, until their acquisition by Pfizer in 2009. Earlier he held management positions at MSD and Searle in the United States and Europe. Mr. Poussot holds a degree from the Ecole Supérieure de Commerce de Paris.